Skip to main content

Table 3 Significant peptide peaks differentiating BTC from healthy volunteers

From: Identification of potential serum peptide biomarkers of biliary tract cancer using MALDI MS profiling

Mass (m/z)

Peak area

Peak area

Fold- change

Wilcoxon test

AUROC†

 

BTC +/- SD

H +/- SD

(BTC vs H)

P value

 

887.2

5.2+/-7.1

1.8+/-0.5

2.82

0.000691

0.79

1263.7

21.8+/-9.9

47.4+/-22.7

0.46

<0.000001

0.91

1350.8

48.3+/-25.7

117.4+/-62.3

0.41

<0.000001

0.92

2082.1

10.0+/-3.4

24.4+/-20.5

0.41

0.0000364

0.86

2210.3

10.9+/-3.8

38.2+/-31.6

0.29

<0.000001

0.92

2554.5

24.8+/-17.8

57.3+/-20.6

0.43

<0.000001

0.91

2903.3

24.1+/-10.0

11.5+/-2.5

2.09

<0.000001

0.97

5805.0

33.0+/-30.9

6.7+/-1.6

4.93

<0.000001

0.96

  1. *Wilcoxon test P values were corrected for multiple testing using the Benjamini-Hochberg adjustment. †Area under the Receiver Operating Characteristic curve.